Phase 4 Chronic Kidney Disease Trial, Recruiting NCT06860711 Sponsor: University of Colorado, Denver Condition: Chronic Kidney Disease
Back to Chronic Kidney Disease

Phase 4 Chronic Kidney Disease Trial, Recruiting

NCT06860711
Recruiting Phase 4

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are older than 18 months of age
  • You have been diagnosed with a moderate level of chronic kidney disease (specifically stages 2 to 3a), confirmed by a specific kidney function blood test done within the last 6 months
  • You are already scheduled to have a urological (urinary system) surgery that requires at least one overnight stay in the hospital

Who may not be able to join:

  • You have been diagnosed with a very mild (stage 1) or more severe (stages 4 or 5) level of chronic kidney disease
  • You have previously had a kidney transplant
  • You have a history of nasal polyps (small growths inside the nose)
  • Your surgery is related to cancer treatment, or you are currently receiving chemotherapy
  • You are pregnant
  • You have a known true allergy to NSAIDs (a common type of pain reliever, such as ibuprofen or naproxen)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 6 July 2026
Phase 4 trials study a drug that has already been approved, monitoring long-term safety and effectiveness in real-world use.

Contact this trial

Principal Investigator: Kyle Rove, MD, Children's Hospital Colorado

Phone: 7209758206

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Phase 4
Registry
ClinicalTrials.gov
Start date
22 July 2025
Est. completion
1 June 2028

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Frequency of Acute Kidney Injury

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 6 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov